ConductScience.org, home

Paper20121758

IPF: new insight on pathogenesis and treatment.

Harari S and 1 other. Allergy, 2010. Cited by 96 papers, by iCite.

Cite this record

ConductScience Library. IPF: new insight on pathogenesis and treatment. Papers, record 20121758. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20121758

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
IPF: new insight on pathogenesis and treatment.
PubMed
Journal
Allergy
PubMed
Year
2010
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
96
iCite
Relative citation ratio, by iCite
2.68
iCite
Revised in PubMed
2022-03-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harari SS
2Caminati AA

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Idiopathic Pulmonary FibrosisMajor topic
Animals
Humans

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05828953Anlotinib Capsules in the Treatment for IPF/PF-ILDsBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by50

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.

PMIDTitleJournalYearIn PapersSource
42400038Identification and functional validation of lactylation-related hub genes in idiopathic pulmonary fibrosis based on multi-omics analysis.Respir Res2026https://conductscience.org/library/papers/42400038PubMed
40848531miR-146b disrupts the epidermal growth factor receptor/transforming growth factor β receptor profibrotic feedforward loop to inhibit lung fibroblast proliferation and differentiation.J Pharmacol Exp Ther2025https://conductscience.org/library/papers/40848531PubMed
40183147Role of Essential Oils and Antioxidants in the Treatment of Fibrosis.Curr Drug Res Rev2025https://conductscience.org/library/papers/40183147PubMed
39346776Role of telomere dysfunction and immune infiltration in idiopathic pulmonary fibrosis: new insights from bioinformatics analysis.Front Genet2024https://conductscience.org/library/papers/39346776PubMed
39129313SPP1 promotes the polarization of M2 macrophages through the Jak2/Stat3 signaling pathway and accelerates the progression of idiopathic pulmonary fibrosis.Int J Mol Med2024https://conductscience.org/library/papers/39129313PubMed
38791861Improving Accessibility to Patients with Interstitial Lung Disease (ILD): Barriers to Early Diagnosis and Timely Treatment in Latin America.Int J Environ Res Public Health2024https://conductscience.org/library/papers/38791861PubMed
38570751Genetic association between smoking and DLCO in idiopathic pulmonary fibrosis patients.BMC Pulm Med2024https://conductscience.org/library/papers/38570751PubMed
37995089Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis.Pharmacol Rep2024https://conductscience.org/library/papers/37995089PubMed
37523510NFATc3 Promotes Pulmonary Inflammation and Fibrosis by Regulating Production of CCL2 and CXCL2 in Macrophages.Aging Dis2023https://conductscience.org/library/papers/37523510PubMed
37416778FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis.Int J Biol Sci2023https://conductscience.org/library/papers/37416778PubMed
37254717Searching for Novel Candidate Small Molecules for Ameliorating Idiopathic Pulmonary Fibrosis: a Narrative Review.Biomol Ther (Seoul)2023https://conductscience.org/library/papers/37254717PubMed
36830702CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential.Biomolecules2023https://conductscience.org/library/papers/36830702PubMed
36139759The Role of Nrf2 in Pulmonary Fibrosis: Molecular Mechanisms and Treatment Approaches.Antioxidants (Basel)2022https://conductscience.org/library/papers/36139759PubMed
35059991Influence of chest wall conformation on spirometry parameters and outcome in mild-to-moderate idiopathic pulmonary fibrosis.Intern Emerg Med2022https://conductscience.org/library/papers/35059991PubMed
35003060Analyses of circRNA and mRNA Profiles in Vogt-Koyanagi-Harada Disease.Front Immunol2021https://conductscience.org/library/papers/35003060PubMed
34744424Microbiota and IPF: hidden and detected relationships.Sarcoidosis Vasc Diffuse Lung Dis2021https://conductscience.org/library/papers/34744424PubMed
34275342The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?Ther Adv Respir Dis2021https://conductscience.org/library/papers/34275342PubMed
32899090Using bioinformatics approach identifies key genes and pathways in idiopathic pulmonary fibrosis.Medicine (Baltimore)2020https://conductscience.org/library/papers/32899090PubMed
32712053TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.Biochem Pharmacol2020https://conductscience.org/library/papers/32712053PubMed
32692932Type I Collagen Signaling Regulates Opposing Fibrotic Pathways through α2β1 Integrin.Am J Respir Cell Mol Biol2020https://conductscience.org/library/papers/32692932PubMed

See all 50 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20121758

GET https://conductscience.org/api/papers/v1/20121758/cited_by?page=2